WallStreetZenWallStreetZen

NASDAQ: PVLA
Palvella Therapeutics Inc Stock Ownership - Who owns Palvella Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Palvella Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
George M. JenkinsDirector2024-12-184,000$12.93
$51.72kBuy
Adar1 Capital Management LLC10% Owner2024-08-12757$15.88
$12.02kBuy
Adar1 Capital Management LLC10% Owner2024-08-122,243$15.88
$35.62kBuy
Adar1 Capital Management LLC10% Owner2024-08-093,000$14.89
$44.68kBuy
James A. GeraghtyDirector2024-08-071$1.00
$1.00Buy

1 of 1

PVLA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PVLA insiders and whales buy or sell their stock.

PVLA Shareholders

What type of owners hold Palvella Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Aquilo Capital Management LLC278.40%3,675,530$48.44MInsider
Wes Kaupinen121.74%1,607,228$21.18MInsider
Bvf Inc19.51%257,626$3.40MInstitution
George M. Jenkins14.52%191,697$2.53MInsider
Adar1 Capital Management LLC10.96%144,641$1.91MInstitution
Adar1 Capital Management LLC10.96%144,641$1.91MInsider
Dellora Investments LP10.69%141,079$1.86MInsider
Todd C. Davis8.52%112,547$1.48MInsider
Chau Quang Khuong4.95%65,398$861.95kInsider
Allan Reine4.92%65,000$856.70kInsider

1 of 3

PVLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PVLA8.91%91.09%Net BuyingNet Buying
CRVO4.87%95.13%Net Buying
SYBX5.66%94.34%Net SellingNet Selling
NNVC2.50%97.50%
IBO0.26%70.20%Net BuyingNet Selling
View Top Biotech Stocks

Palvella Therapeutics Stock Ownership FAQ

Who owns Palvella Therapeutics?

Palvella Therapeutics (NASDAQ: PVLA) is owned by 45.87% institutional shareholders, 468.78% Palvella Therapeutics insiders, and 0.00% retail investors. Aquilo Capital Management LLC is the largest individual Palvella Therapeutics shareholder, owning 3.68M shares representing 278.40% of the company. Aquilo Capital Management LLC's Palvella Therapeutics shares are currently valued at $48.44M.

If you're new to stock investing, here's how to buy Palvella Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.